RxDoctor Payments Data

Steven Smith

Family Medicine · Indianapolis, INNPI 1841289972

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 48.2% of the total. Reporting peaked in 2019 at $465 and has fallen 91.9% since, to $38 in 2022.

$673in general payments, 2019–2025

Across 27 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$324
  • Novo Nordisk$63
  • Lilly USA, LLC$47
  • Scilex Pharmaceuticals Inc.$40
  • Amgen$29
  • Takeda Pharmaceuticals U.S.A., Inc.$27
  • plus $143 from 9 others
$2,573,706in research payments, 2019–2025

Across 33 payments — averaging $77,991 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2.5M
  • Sanofi US Services Inc.$94K

What the payments were for

  • Food & beverage$673100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$673 in reported general payments places this provider in the 55th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Other family medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →